— with a 99.9999% kill rate!
In tests of its anti-fungal capabilities, Banixx killed 97% of Aspergillus niger and 99% of Candida albicans. All tests were conducted by BioVir Labs, an independent, accredited laboratory. View the data below.
Banixx was tested in-vitro to assess the acute ocular toxicity after topical application at NC State Veterinary School Comparative Ophthamology Research Laboratory under the supervision of Brian Gilger DVM, MS, DACVO, DABT.
The purpose of the study was to evaluate the potential acute ocular toxicity of Banixx, as measured by the conversion of MTT by EpiOcular human cell constructs after exposure to each test or reference substances for 30 minutes. Additionally, acute ocular toxicity was evaluated using histopathology of the cell constructs, comparing the microscopic tissue damage between the test and references substances. Results are summarized from Dr. Gilger's report, In Vitro Acute Ocular Toxicity of Banixx after Topical Application below:
Histopathology: The negative control treated and Banixx-treated cells had no appreciable histologic changes. All cells appeared normal and the thickness of the tissue were uniform. However, the two positive control tissues had variable areas of cellular loss.
Conclusions: ..."Based on these findings, therefore, the test article, Banixx, which resulted in a mean cellular viability of 94.79% on the EpiOcular culture system after a 30-minute exposure, would be classified as a non-ocular irritant. Furthermore, the 94.79% cellular viability was similar to that of deionized water." There was no difference between the deionized water treated and Banixx treated samples.
Performed by BioVir Laboratories, Inc.
In separate tests, one to ten million bacterial organisms of Salmonella choleraesuis, Pseudomonas aeruginosa, and Staphylococcus aureus were added to Banixx and results were tested at 0, 1, 3, 5, and 10 minutes later. All tests were run in triplicate. The results are presented below as kill-curves; that is, they illustrate the reduction of organisms over time of exposure. In all tests, the bacterial organisms were "killed", or reduced, to below the detection limit of 1 cfu per mL within ten minutes. The data is presented below.
In separate tests, 500,000 to one million of Candida albicans and Aspergillus niger spores were added to Banixx and results were tested at 1, 2, 5, and 10 minutes later. All tests were run in triplicate. The results are presented below as kill-curves; that is, they illustrate the reduction of organisms over time of exposure. Candida albicans was reduced by about 99% and Aspergillus niger spores were reduced by <95% within 10 minutes. The data is presented below.
Two years of testing by a highly-credentialed research veterinarian, produced credible, documented results that allow us to bring Banixx Horse & Pet Care to market. His findings were published in the July 2005 issue of the Journal of Equine Veterinary Science, the official journal of the World Equine Veterinary Association.